Efficacy of tranexamic acid in radical prostatectomy
Reducing blood loss during radical prostatectomy remains an urgent problem at the present time. In order to assess the effectiveness of tranexamic acid as a method of reducing surgical blood loss during radical prostatectomy, 58 patients were examined in the pre- and postoperative periods. The control group included patients with standard prevention of thromboembolic complications and standard perioperative therapy. The study group included patients to whom standard therapy was supplemented with intravenous administration of the drug "Tranexam" with a dosage of 1000 mg in 20 minutes. It has been established that intravenous infusion of tranexamic acid reduces surgical blood loss in patients who have undergone radical prostatectomy. The data obtained as a result of the study make it possible reduce surgical blood loss.